Moving Forward in Translational Models
Translational medicine aims to bridge the gap between basic and clinical science. New translational models help predict drug efficacy and safety, but need collaboration.
March 3, 2025
by Suzanne Elvidge
Decentralising research: Virtual clinical trials
Clinical trials are vital as the basis of developing safe and effective drugs, but they can be slow and expensive.
May 14, 2024
by Suzanne Elvidge
Vetter Looks Ahead to Further Expansions to Meet Supply Chain Demand
Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), announces additional investments as part of its long-term dedication to customer partnerships.
November 6, 2023
by B3C newswire
Atriva Therapeutics announces publication of Proof of Concept (POC) / Phase 2a RESPIRE study data with zapnometinib in patients hospitalized with COVID-19
Atriva Therapeutics GmbH, a biopharmaceutical company pioneering the development of host-targeting antiviral therapies, announced today the publication of proof-of-concept data for its oral MEK inhibitor.
November 6, 2023
by B3C newswire
MC2 Therapeutics Acquires Option to Phase 2 Oral Drug Candidate for Hidradenitis Suppurativa and Other Indications
MC2 Therapeutics announced today that it has acquired option rights from Regranion, LLC to exclusively license Regranion’s RGRN-305 for the treatment of all human diseases, incl, oral treatment of HS globally, excluding the greater China region.
November 6, 2023
by B3C newswire
Eurofins Awarded U.S. Government Agreement To Expand National COVID-19 Testing
Clinical Enterprise Inc., a Eurofins Scientific company, announced it has been awarded a U.S. Government agreement to expand national COVID-19 testing.
June 2, 2021
by americanpharmaceuticalreview
Clinical Ink Adds Executives
Clinical Ink, a global clinical trial technology company, has appointed CCO Chris Crucitti, COO Brian Donahue, and VP Project Operations Bill Barrasso. All three positions are newly created to help manage the company’s eCOA, ePRO+, DDC, and eConsent ...
May 6, 2021
by contractpharma
Pharmaceutical News of the Week | CPhI.CN - Policies
The National Health Commission of China issued the Administrative Measures for the Clinical Use of Oncology Drugs (Draft for Comment) on July 29 in order to strengthen the administration of the clinical use of medical institutions’ oncology drugs.
August 6, 2020
by PharmaSources/Caicai
Pharmaceutical News of the Week (July. 20th-July. 24th) | PharmaSources.com - Updates on R&D
The hottest event of the week was the official kick-off of the centralized procurement of the third batch of pharmaceutical products organized in China, with 86 specifications started to be acquired the basic information.
July 29, 2020
by PharmaSources/Caicai
Pharmaceutical News of the Week (July. 6th-July. 10th) PharmaSources.com - Updates on Policies,Transactions and Others
With the second week of July coming to a close, let’s review the hot events of the pharmaceutical industry this week. The news involved 6 sections: approval, R&D, policies, transactions, listing and miscellany that happened during July 6-10.
July 21, 2020
by PharmaSources/Caicai
Pharmaceutical News of the Week (June. 29th-July. 3rd) | PharmaSources.com - Updates on M&A, IPO and Others
Let’s review the hot events of the pharmaceutical industry this week. The news involved 5 sections: approval, R&D, policies, transactions and listing that happened during June 29-July 3, including 29 pieces.
July 8, 2020
by PharmaSources/Caicai
Pharmaceutical News of the Week (June. 29th-July. 3rd) | PharmaSources.com - Updates on R&D
Let’s review the hot events of the pharmaceutical industry this week. The news involved 5 sections: approval, R&D, policies, transactions and listing that happened during June 29-July 3, including 29 pieces.
July 8, 2020
by PharmaSources/Caicai